Moving forward with the goal of building tomorrow’s healthcare

Fusion Clinical Research works with Contract Research Organisations (CROs), Sponsors and a network of General Practitioners (GPs) to provide medical trials in a community setting.

I'm interested in...

Are you a sponsor, or contract research organisation, seeking a world-class clinical research partner for the next stage of your clinical development program? Click to learn more about the many ways Fusion Clinical Research can assist you.

Are you an expert medical professional interested in playing an active role in clinical research? Click here to learn more about the benefits to you, your patients and your community, and to register your interest.

Are you are interested in helping medical research as a volunteer? Click to learn more about the benefits of this, and to register your interest.


Fusion Clinical Research is owned and operated by CMAX Clinical Research, one of Australia’s oldest and most respected clinical trials units, based in Adelaide,  Australia.

For more than 25 years, CMAX Clinical Research has supported the health of local and international communities through facilitating more than 600 in-human trials resulting in hundreds of new health care products, from medicines to biotech devices.

Fusion Clinical Research works with GPs and health professionals to provide new and hard-to-access treatment options to their patients in a community setting.

Latest Trials

CM8720s RSV Vaccine

 Your Health Clinics - SA, Woodville

Respiratory Syncitial Virus (RSV) is a leading cause of respiratory disease in older people

CM8019s RSV Treatment

 Your Health Clinics - SA, Woodville

Register your interest here.

CM4919s Type 1 or 2 Diabetes

 Your Health Clinics - SA, Woodville

Diabetic Macular Edema
Diabetic retinopathy is a complication of diabetes in which high blood sugar levels cause damage to retinal blood…

CM0120 Cardiovascular

 CMAX 18a North Terrace, Adelaide

In this trial we are looking to evaluate the safety and tolerability of the Study Drug in patients with Elevated Plasma Lipoprotein (a).